🇺🇸 FDA
Patent

US 8309543

Compositions useful as inhibitors of voltage-gated sodium channels

granted A61PA61P1/00A61P1/02

Quick answer

US patent 8309543 (Compositions useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P13/02